XP Health, a Rosenman ADAPT Awardee and leader in digital-first vision care, has secured $33.2 million in Series B funding […]
XP Health Raises $33.2M in Series B to Transform Vision Care

XP Health, a Rosenman ADAPT Awardee and leader in digital-first vision care, has secured $33.2 million in Series B funding […]
Oshi Health, a Rosenman Institute 2020 ADAPT Awardee, announced the successful close of a $60M Series C funding round. Oshi […]
Summer Health, a Rosenman Institute 2023 ADAPT finalist, has secured $12M in Series A funding, co-led by 7wire Ventures and […]
Earlier this year, Neurovalens announced the 2022 Rosenman Innovator has received medical device clearance from the FDA to treat anxiety […]
The 2023 ADAPT Finalist has raised a $14 million Series A funding round to enhance Backpack Healthcare’s technology platform, expand […]
ConKay Medical Systems is a 2023 Rosenman Innovator and medtech start-up company. Conkay’s innovative technology helps treat patients suffering from […]
The FDA has granted 510(k) clearance to the ZETO ONE, an innovative next-generation EEG Brain Monitoring product. Zeto’s Founder, Aswin […]
2023 Rosenman Innovator, Averto Medical, has raised an oversubscribed $30.5 million Series A financing. This financing will support advancing Averto […]
The 2023 Rosenman Innovator raised $6M in funding to expand its virtual dermatology clinic services The 2023 Rosenman Innovator raised […]
2022 ADAPT Finalist, Midi Health, closed a $60M Series B funding round San Francisco – 2022 ADAPT Finalist, Midi Health, […]